Comparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting Stents
Not Applicable
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- Device: balloon angioplasty with Pantera LuxDevice: balloon angioplasty with SeQuent Please
- Registration Number
- NCT02528474
- Lead Sponsor
- Yonsei University
- Brief Summary
Drug-coated balloon technology (DCB) has recently attracted considerable interest as a promising alternative treatment option, particularly in the setting of in-stent restenosis (ISR). Optical coherence tomographic finding of restenosis lesions in drug-eluting stents (DESs) after Balloon Angioplasty with Two Different Paclitaxel-Coated Balloons will be compared between two paclitaxel-coated balloon devices; Pantera Lux™ and SeQuent® Please.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Patients ≥ 19 years old
- Patients eligible for percutaneous coronary intervention
- Single or more lesion(s) of restenosis requiring angioplasty in drug-eluting stent
- Reference vessel diameter of target lesion ≥2.5 mm
Read More
Exclusion Criteria
- Cardiogenic shock
- Bifurcation lesion or totally occluded lesion
- Unprotected left main trunk lesion
- Allergies or hypersensitivities to antiplatelet, anticoagulation therapy, contrast media, or paclitaxel
- Heavy calcified (definite calcified lesions on angiogram) or extremely tortuous lesions
- Pregnant women or women with potential childbearing
- Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
- Inability to understand or read the informed content
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pantera Lux balloon angioplasty with Pantera Lux - SeQuent Please balloon angioplasty with SeQuent Please -
- Primary Outcome Measures
Name Time Method Neointimal thickness & area 9 months measured by OCT analysis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine
🇰🇷Seoul, Korea, Republic of